ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,906Medicare Part D Prescriptions Filled, Including Refills

Rank: 200 out of 680

$557K Total Retail Price of All Prescriptions

Rank: 248 out of 680

483 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 483 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

21% of this provider’s 483 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 9,308 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 434 387 1 1
HYDROCODONE-ACETAMINOPHEN 406 320 S3 2 4
LEVOTHYROXINE SODIUM 377 346 3 2
FUROSEMIDE 326 289 4 6
OMEPRAZOLE 266 239 5 7
POTASSIUM CHLORIDE 266 238 5 14
SIMVASTATIN 252 232 7 3
GABAPENTIN 238 165 8 15
LISINOPRIL 225 219 9 5
LOSARTAN POTASSIUM 184 180 10 21
HYDROCHLOROTHIAZIDE 170 158 11 9
WARFARIN SODIUM 157 141 12 20
PRAVASTATIN SODIUM 156 142 13 10
METFORMIN HCL 143 113 14 8
DOXYCYCLINE HYCLATE 140 88 15 95
METOPROLOL SUCCINATE 140 106 15 13
CITALOPRAM HBR 131 129 17 22
METOPROLOL TARTRATE 129 107 18 12
ZOLPIDEM TARTRATE 124 105 19 17
BYSTOLIC 108 105 20 79
ATORVASTATIN CALCIUM 108 94 20 11
DIGOXIN 105 99 22 58
SULFAMETHOXAZOLE-TRIMETHOPRIM 105 53 22 94
CARVEDILOL 104 97 24 23
TRAMADOL HCL 95 76 25 18
FENOFIBRATE 94 90 26 66
CIPROFLOXACIN HCL 93 74 27 57
VYTORIN 92 80 28 152
CRESTOR 92 80 28 25
SANTYL 90 59 30 170
RAMIPRIL 82 79 31 69
ESCITALOPRAM OXALATE 81 75 32 45
AZITHROMYCIN 81 70 32 42
CYMBALTA 80 60 34 46
FAMOTIDINE 75 69 35 89
SPIRONOLACTONE 69 68 36 82
CLOPIDOGREL 67 51 37 26
ALLOPURINOL 67 67 37 33
NAMENDA 66 66 39 35
TRAZODONE HCL 64 50 40 48
PENICILLIN V POTASSIUM 64 27 40 321
PLAVIX 64 48 40 39
AMLODIPINE BESYLATE-BENAZEPRIL 62 62 43 43
GLIMEPIRIDE 62 59 43 29
LOSARTAN-HYDROCHLOROTHIAZIDE 61 60 45 51
ISOSORBIDE MONONITRATE ER 60 60 46 59
LANTUS 58 41 47 49
JANUVIA 57 53 48 60
BENAZEPRIL HCL 56 41 49 40
LABETALOL HCL 56 56 49 158
SYNTHROID 56 45 49 38
FLUTICASONE PROPIONATE 52 47 52 41
DIOVAN 51 31 53 31
PANTOPRAZOLE SODIUM 51 48 53 30
EXELON 50 50 55 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 4, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.